• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. HEALON ENDOCOAT; OVDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. HEALON ENDOCOAT; OVDS Back to Search Results
Model Number VT585
Device Problem Contamination (1120)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/05/2019
Event Type  malfunction  
Manufacturer Narrative
If implanted; give date: n/a (not applicable).The healon endocoat is not an implantable device.If explanted; give date: n/a (not applicable).The healon endocoat is not an implantable device; therefore, not explanted.(b)(6).All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
It was reported that upon injecting the healon into patient's eye, a black fiber was found in the ovd (ophthalmic viscoelastic device).Further information provided that a second fiber was found as the doctor injected more ovd into patient's eye.The doctor used forceps to get all the fibers out.The patient was not noted to experience any pain in the process.No additional information provided.
 
Manufacturer Narrative
Device available for evaluation: yes.Returned to manufacturer on: 3/19/2019.Device returned to manufacturer: yes.Device evaluation: evaluation of the returned units confirmed returned fibers as identified by the customer.Visual evaluation under magnification could not confirm the presence of any particles or fibers observed within the remaining product solution.Characterization of the returned fibers confirmed the material to be composed of cellulose.Visible cellulose fibers are not inherent to the manufacturing process.Due to the opened nature of the return, the source of the returned fiber could not be conclusively confirmed.No manufacturing root cause could be determined.Manufacturing records review: the manufacturing review indicates the lot was manufactured per procedure and meets the product specifications.Review of the complaint database over the past year indicates 5 potentially similar complaints have been received for healon endocoat products.Complaint review indicates there have been no trends identified for particulates within solution for all manufactured syringe products.Conclusion: as a result of this investigation, no specific manufacturing root cause could be determined.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
 
Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are (b)(4) and (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEALON ENDOCOAT
Type of Device
OVDS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key8466979
MDR Text Key140595155
Report Number3004750704-2019-00006
Device Sequence Number1
Product Code LZP
UDI-Device Identifier05050474540354
UDI-Public(01)05050474540354(17)210531(10)027341
Combination Product (y/n)Y
PMA/PMN Number
P110007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 01/01/2005,11/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2021
Device Model NumberVT585
Device Catalogue NumberVT585
Device Lot Number027341
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/19/2019
Was the Report Sent to FDA? No
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 03/05/2019
Initial Date FDA Received03/29/2019
Supplement Dates Manufacturer Received04/09/2019
10/25/2020
Supplement Dates FDA Received05/07/2019
11/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-